Controlling the balance between immunity and immunopathology is crucial for host resistance to pathogens. After infection, activation of the hypothalamic-pituitary-adrenal (HPA) axis leads to the production of glucocorticoids. However, the pleiotropic effects of these steroid hormones make it difficult to delineate their precise role(s) in vivo. Here we found that the regulation of natural killer (NK) cell function by the glucocorticoid receptor (GR) was required for host survival after infection with mouse cytomegalovirus (MCMV). Mechanistically, endogenous glucocorticoids produced shortly after infection induced selective and tissue-specific expression of the checkpoint receptor PD-1 on NK cells. This glucocorticoid-PD-1 pathway limited production of the cytokine IFN-γ by spleen NK cells, which prevented immunopathology. Notably, this regulation did not compromise viral clearance. Thus, the fine tuning of NK cell functions by the HPA axis preserved tissue integrity without impairing pathogen elimination, which reveals a novel aspect of neuroimmune regulation.
T he immune system protects the host organism against infectious diseases, principally by eradicating infectious agents. However, pathogen elimination frequently entails collateral tissue damage and inflammation, which potentially decreases host fitness 1 . Neuroendocrine-immune system interactions have an important role in these regulatory processes, but the mechanisms involved remain unclear 2, 3 . Endogenous glucocorticoids (cortisol in humans, and corticosterone in rodents) are essential steroid hormones that regulate many physiological and developmental processes. They are synthesized in the adrenal cortex after activation of the hypothalamic-pituitary-adrenal (HPA) axis, a neural-endocrine core for coordinating physiological responses to external stimuli 4 . Glucocorticoids released into the blood diffuse through cell membranes to bind cytosolic glucocorticoid receptor (GR), which is ubiquitously expressed and induces changes in gene expression 5 . The HPA neural-endocrine pathway restores homeostasis by limiting and resolving inflammation in many conditions 2 . In models of systemic inflammation, such as lipopolysaccharide-induced sepsis, glucocorticoids specifically inhibit the production of pro-inflammatory cytokines in several types of immune cells [6] [7] [8] [9] .
The HPA axis is also activated during infection with viruses such as influenza virus 10 or cytomegalovirus (CMV) 11 . Murine CMV (MCMV) is a beta-herpesvirus used as a model for systemic infection with human CMV, which can cause severe disease, especially in immunocompromised people. Mice rendered deficient in glucocorticoids by adrenalectomy are more susceptible to MCMV-induced death, due to the deleterious effects of cytokine-induced hyperinflammation, and resistance is restored by corticosterone replacement 12 . Finally, glucocorticoids are clinically effective against many inflammatory and autoimmune diseases 13 . In all these conditions, the underlying mechanisms used by glucocorticoids have remained unclear, because GRs are expressed by many hematopoietic and non-hematopoietic cells and can affect multiple signaling pathways.
During acute infection, the cytokine interferon-γ (IFN-γ ) produced by innate lymphoid cells (ILCs) is essential for antiviral defense [14] [15] [16] . These IFN-γ -producing ILCs include natural killer (NK) cells in the spleen and liver and group 1 ILCs (ILC1s) in the liver, which all express GR 6 . Here we investigated the role of GRs in ILC subsets of relevance during infection with MCMV through the use of mice with conditional deletion of the gene encoding GR in ILCs expressing the activating NK cell receptor NCR1 (NKp46), which include NK cells, ILC1s and a subset of ILC3s. We found that endogenous glucocorticoids produced rapidly after infection induced selective and tissue-specific expression of the immunological checkpoint receptor PD-1 on the surface of spleen NK cells. Concomitantly, the expression of PD-1 ligands was upregulated in several subsets of immune cells. PD-1 signaling was required for host survival after infection and acted by limiting the production of IFN-γ by NK cells in the spleen, which prevented immunopathology. This neuroendocrine-immune system axis controlled immunotolerance but did not impair viral clearance. Our findings therefore demonstrate a major role for the HPA axis in promoting host resistance to an infectious disease through regulation of the PD-1 inhibitory pathway in an ILC subset.
Results
The regulation of NK cell functions by glucocorticoids is organ specific. During acute infection with MCMV, high levels of viral replication are seen in the spleen and the liver 17 . In these organs, NK cells are required for host resistance to infection, and they mediate their anti-viral function through cytokine-and killingdependent mechanisms 18 . Consistent with published findings 11, 19 , infection of C57BL/6 J wild-type mice with MCMV induced the Articles NATuRe IMMuNoloGy release of corticosterone into the bloodstream, with a peak at 36 h after infection ( Fig. 1a ), which suggested that the HPA axis might have a role during the early phase of the infection, when NK cells are activated 14 . We first analyzed the effect of glucocorticoids on the cytotoxic activity of spleen CD3 -NCR1 + NK cells in vitro by stimulating splenocytes isolated from C57BL/6 J wild-type mice with antibody to the activating NK cell receptor NK1.1 or with the phorbol ester PMA and ionomycin. Treatment with corticosterone had no effect on the degranulation of NK cells, as assessed by measurement of the expression of lysosome-associated membrane protein-1 (also known as CD107a) ( Supplementary Fig. 1a ). We then analyzed the role of the GR pathway in NCR1 + ILCs in vivo through the use of Ncr1 iCre/+ Nr3c1 loxP/loxP mice (called 'GR Ncr1-iCre mice' here), in which loxP-flanked alleles encoding GR (Nr3c1 loxP/loxP ) are specifically deleted in NCR1 + cells that express Cre recombinase 6, 20, 21 . Sex-matched Ncr1 iCre/+ Nr3c1 +/+ littermates (called 'WT Ncr1-iCre mice' here), in which Cre recombinase is expressed in NCR1 + cells but Nr3cr1 is not deleted, were used throughout as control mice, unless specified otherwise. In steady-state conditions, NCR1 + ILCs in GR Ncr1-iCre mice (i.e., NK cells, ILC1s and a subset of ILC3s) show normal development, maturation and function 6 . We infected GR Ncr1-iCre and WT Ncr1-iCre littermates with MCMV and analyzed their immune responses at 44 h after infection, after the concentration of corticosterone in blood had peaked. The concentration of corticosterone in the serum of GR Ncr1-iCre mice was similar to that in the serum of WT Ncr1-iCre mice ( Supplementary Fig. 1b ). The expression of granzyme B, a surrogate marker of NK cell cytotoxicity, was upregulated similarly in NK1.1 + NCR1 + DX5 + CD49a -NK cells from GR Ncr1-iCre mice and those from WT Ncr1-iCre mice, both in the spleen and in the liver ( Supplementary Fig. 1c ). In contrast, the expression of IFN-γ was higher in spleen GR Ncr1-iCre NK cells than in spleen WT Ncr1-iCre NK cells, as measured by mean fluorescence intensity and the frequency of IFN-γ + cells ( Fig. 1b and Supplementary Fig. 1d ). Although corticosterone is known to have systemic distribution, the expression of IFN-γ by liver GR Ncr1-iCre NCR1 + NK cells and ILC1s was similar to that of their WT Ncr1-iCre counterparts (Fig. 1c,d ), which suggested that the effect of glucocorticoids was tissue specific.
Histological analysis of the spleen indicated that GR Ncr1-iCre mice had more-substantial lesions, associated with coalescing and granulomatous necrotic splenitis in the marginal zone, than did WT Ncr1-iCre mice ( Fig. 2a,b ). In contrast, no significant difference between GR Ncr1-iCre mice and WT Ncr1-iCre mice was observed in the nature or extent of the liver lesions, with mild multifocal pyogranulomatous and necrotic hepatitis in mice of each genotype ( Fig. 2c,d ). The viral load in the spleen and liver of GR Ncr1-iCre was similar to that in WT Ncr1-iCre mice ( Fig. 2e ), which suggested that the inflammation-induced tissue damage was not due to an impairment of viral clearance. NCR1 + ILC3s are known to express GR, and the gene encoding GR is also deleted in NCR1 + ILC3s from GR Ncr1-iCre mice 6 . These ILC3s reside mostly in mucosal tissues, where they produce the cytokines IL-22 and IL-17, but not IFN-γ 22 , and thus they are thought to have minimal involvement in the immune response to MCMV. Nonetheless, we assessed the effect of endogenous glucocorticoids on these cells after infection with MCMV. Such infection did not induce an increase in the production of IL-22 or IL-17 in NCR1 + ILC3 from the small intestine of WT Ncr1-iCre or GR Ncr1-iCre mice (Supplementary Fig. 2a-d ). The frequency of NCR1 + ILC3s in the small intestine was also unaffected ( Supplementary Fig. 2e ), which suggested that NCR1 + ILC3s did not have a major effect on the immune response to infection with MCMV. Collectively, these results indicated that the responsiveness of NCR1 + ILCs to glucocorticoids produced during acute infection with MCMV controlled spleen inflammation and specifically regulated the production of IFN-γ by spleen NK cells.
Endogenous glucocorticoids induce PD-1 expression on spleen NK cells. Next we performed RNA-based next-generation 
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sequencing on spleen CD3 -CD19 -NK1.1 + NCR1 + DX5 + NK cells, liver CD3 -CD19 -NK1.1 + NCR1 + DX5 + CD49a -NK cells and liver CD3 -CD19 -NK1.1 + NCR1 + DX5 -CD49a + ILC1s sorted from GR Ncr1-iCre and WT Ncr1-iCre mice at 44 h after infection with MCMV ( Supplementary Fig. 3 ). Pairwise comparison of the two genotypes for gene expression by spleen NK cells, liver NK cells and liver ILC1s identified genes expressed differentially by cells of the two genotypes for each ILC subset (Supplementary Table 1 ). Unsupervised genome-wide analysis indicated that the GR-dependent modifications of the transcriptome were different in spleen NK cells, liver NK cells and liver ILC1s ( Supplementary Table 1 ), which suggested that the regulation of gene expression by glucocorticoids was specific to both organ and cell lineage in vivo. To identify candidate genes associated with the selective hyper-inflammation observed in the spleen of GR Ncr1-iCre mice, we focused on genes that were expressed differentially by WT Ncr1-iCre spleen NK cells relative to their expression by GR Ncr1-iCre spleen NK cells. In addition to the expression of Nr3c1 (which encodes GR), the expression of Tsc22d3 (which encodes the glucocorticoid-induced protein GILZ) and of Pdcd1 (which encodes PD-1) was significantly downregulated in spleen NK cells from GR Ncr1-iCre mice after infection, relative to such expression in spleen NK cells from their WT Ncr1-iCre littermates ( Fig. 3a and Supplementary Table 1 ). Consistent with the rapid and ubiquitous induction of Tsc22d3 by glucocorticoids in many cell types and inflammatory conditions 23 , the expression of Tsc22d3 in both spleen NK cells and liver NK cells from GR Ncr1-iCre after infection was different from that in their WT Ncr1-iCre counterparts ( Supplementary Table 1 ). GILZ is a mediator of the anti-inflammatory effects of glucocorticoids and regulates the survival, homeostasis and apoptosis of various cell types, including lymphoid cells 24, 25 . We assessed the proliferation and apoptosis of NK cells in the spleen and liver of GR Ncr1-iCre mice and their WT Ncr1-iCre littermates at 44 h after infection with MCMV, through the use of staining with proliferation marker Ki67 and with the apoptosis marker annexin V and propidium iodide, followed by flow cytometry. Despite the downregulation of Tsc22d3 in spleen and liver GR Ncr1-iCre NK cells, there was no difference in the proliferation or apoptosis of spleen and liver GR Ncr1-iCre NK cells relative to that of their WT Ncr1-iCre counterparts ( Supplementary Fig. 4a,b ). The homeostasis of liver ILC1s in GR Ncr1-iCre mice was also similar to that in WT Ncr1-iCre mice ( Supplementary Fig. 4c ), which suggested that GILZ did not have a major role in the selective immunopathology observed in the spleen of GR Ncr1-iCre mice.
In contrast to the expression of Tsc22d3, differential expression of Pdcd1 by cells of the two genotypes was observed selectively for spleen NK cells, not for liver NK cells ( Supplementary Table 1 ). In addition, Pdcd1 expression in liver ILC1s from MCMV-infected GR Ncr1-iCre mice was similar to that in such cells from MCMVinfected WT Ncr1-iCre mice. PD-1 is an inhibitory cell-surface receptor that downregulates T cell activity 26 . PD-1 protein was not expressed on the surface of spleen or liver NK cells from uninfected GR Ncr1-iCre or WT Ncr1-iCre mice, but it was detected on spleen NK cells from MCMV-infected WT Ncr1-iCre mice at 44 h after infection ( Fig. 3b ). Notably, we did not detect PD-1 in spleen NK cells from MCMVinfected GR Ncr1-iCre mice (Fig. 3b ), which showed that the induction of PD-1 was dependent on the glucocorticoid-GR pathway. PD-1 expression was not detected on spleen macrophages, neutrophils or dendritic cells in either uninfected wild-type mice or MCMVinfected wild-type mice at 44 h after infection ( Supplementary Fig. 5 ). In the spleen of uninfected WT Ncr1-iCre and GR Ncr1-iCre mice, a discrete subset of T cells (less than 4%) had low basal expression of PD-1, but this T cell subset did not expand, and PD-1 expression on T cells did not change after infection with MCMV in mice of either genotype ( Fig. 3c ). Expression of PD-1 was not detected on liver NK cells or ILC1s (Fig. 3d,e ), consistent with the transcriptomic data. Similar results were obtained with two different clones of antibody to PD-1 (J43 and RMP1-30) (Fig. 3b ). These data indicated that glucocorticoids released after infection with MCMV induced the GR-dependent de novo expression of PD-1 on spleen NK cells by regulating Pdcd1 transcription.
NK cell expression of PD-1 depends on the cytokine microenvironment.
Liver NK cells expressed GR both at steady state 6 and after infection with MCMV ( Supplementary Fig. 6a ). Tsc22d3 expression was downregulated in spleen and liver GR Ncr1-iCre NK cells similarly to its downregulation in their WT Ncr1-iCre counterparts ( Supplementary  Table 1 ), which indicated that the liver NK cells were responsive to GR signaling. Because the lack of expression of PD-1 on liver NK cells, in contrast to its expression on spleen NK cells, could not be explained by impaired responsiveness to glucocorticoids, we investigated whether it was dependent on the presence of tissue-specific 
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In contrast, expression of Il12 mRNA was upregulated by infection to a greater extent in the liver than in the spleen, and Il15 mRNA expression was higher exclusively in the spleen of infected mice relative to that in uninfected mice (Fig. 4a ). Similar expression patterns were observed for Il12, Il15 and Il18 in WT Ncr1-iCre mice and GR Ncr1-iCre mice (data not shown). These data suggested that during infection with MCMV, the cytokine microenvironment in the liver differed from that in the spleen. Next we determined whether various combinations of cytokines in culture medium modified the effect of the activation of GR on NK cells in vitro. We stimulated splenocytes from WT Ncr1-iCre or GR Ncr1-iCre mice for 48 h with various combinations of IL-12, IL-15 and IL-18 in the presence or absence of corticosterone. In the absence of corticosterone, PD-1 expression was not induced on CD3 -NCR1 + NK1.1 + NK cells or CD3 + T cells ( Fig. 4b and data not shown). Similarly, corticosterone, alone or in combination with IL-15 or with IL-12 and IL-15, did not induce the expression of PD-1 on NK cells or T cells of either genotype ( Fig. 4b and data not shown). In contrast, treatment with corticosterone, IL-15 and IL-18 induced PD-1 expression, in a dose-dependent manner, on NK cells from WT Ncr1-iCre mice but not on those from GR Ncr1-iCre mice (Fig. 4b,c ). This treatment did not induce the expression of PD-1 on T cells from WT Ncr1-iCre or GR Ncr1-iCre mice ( Fig. 4b and data not shown). The addition of IL-12 abolished the corticosterone-, IL-15-and IL-18-dependent induction of PD-1 expression in WT Ncr1-iCre NK cells ( Fig. 4b ). Similar results were obtained for NK1.1 + NCR1 + NK cells enriched from splenocytes (86-89% purity) and stimulated in the same way ( Fig. 4d and data not shown), which suggested that the effect of IL-15 and IL-18 on NK cells was cell intrinsic. These data indicated that the induction of PD-1 expression by GR was specific to the cell type and was dependent on the cytokine microenvironment of NK cells.
The GR-PD-1 axis inhibits IFN-γ production in spleen NK cells. The activating NK cell receptor Ly49H mediates resistance of C57BL/6 J mice to infection with MCMV by specifically binding the virus-encoded protein m157 27 . Thus, we investigated the link between the expression of PD-1 and that of Ly49H on spleen NK cells during infection with MCMV. At 44 h after the infection of wildtype C57BL/6 J mice, PD-1 expression was upregulated similarly on Ly49H + and Ly49Hspleen NK subsets ( Supplementary Fig. 7a ). Moreover, the frequency of Ly49H + spleen NK cells in GR Ncr1-iCre mice at 5 d after infection was similar to that in WT Ncr1-iCre mice ( Supplementary Fig. 7b ), which suggested that GR signaling and PD-1 expression did not affect the population expansion of the m157-specific NK cells during infection with MCMV.
To further investigate whether PD-1 expression and signaling in spleen NK cells might have functional relevance, we determined whether the PD-1 ligands PD-L1 and PD-L2 were expressed in wildtype mice during infection with MCMV. Cytofluorimetric analysis revealed that PD-L1 expression was upregulated on macrophages, Liver NK cells PD-1 MFI (relative) 
NATuRe IMMuNoloGy dendritic cells, neutrophils, T cells, B cells and NK cells from the spleen of MCMV-infected wild-type mice relative to its expression on such cells from the spleen of uninfected wild-type mice (Fig. 5a ), while PD-L2 was expressed only on dendritic cells after infection with MCMV ( Fig. 5b) . To determine whether the potential engagement of PD-1 by its ligands controlled the function of NK cells in the spleen, we infected WT Ncr1-iCre and GR Ncr1-iCre mice with MCMV, followed by the administration of a PD-1-blocking antibody or isotype-matched control antibody. The antibodies were injected intraperitoneally 1 d after infection, before activation of the HPA axis and the release of glucocorticoids into the bloodstream. At 44 h after infection, the frequency of IFN-γ + spleen NK cells in WT Ncr1-iCre mice that received the PD-1-blocking antibody (about 61%) was higher than that of WT Ncr1-iCre mice given injection of the control antibody (about 33%) but was similar to that in GR Ncr1-iCre mice treated with the control antibody (54%) (Fig. 5c ). There was no greater frequency of IFN-γ + spleen NK cells in GR Ncr1-iCre mice that received the PD-1-blocking antibody than in mice given injection of the control antibody ( Fig. 5c ), indicative of a strict dependence of the effect of PD-1 on GR-expressing NCR1 + NK cells. Moreover, blockade of PD-1 had no effect on the frequency of IFN-γ + NK cells in the liver of WT Ncr1-iCre mice, relative to the effect of treatment with the control antibody ( Fig. 5d) , consistent with the lack of PD-1 expression on liver NK cells. Thus, during infection with MCMV, PD-1 signaling in spleen NK cells limited IFN-γ production by these cells. This regulation occurred in the spleen but not in the liver.
GR and PD-1 are required for host resistance to infection with MCMV.
To assess the effect of the glucocorticoid-PD-1 axis on host resistance to viral infection, we infected 9-to 10-week-old GR Ncr1-iCre and WT Ncr1-iCre mice intraperitoneally with a median lethal dose (LD 50 ) of MCMV. GR Ncr1-iCre mice had greater mortality (100%) than that of their WT Ncr1-iCre littermates (62%) (Fig. 6a ), which indicated that glucocorticoid signaling in NCR1 + ILCs was required for host resistance to viral infection. To evaluate the specific contribution of the PD-1-PD-1 ligand interaction to such host resistance, we infected female wild-type C57BL/6 J mice with the LD 50 of MCMV, followed by intraperitoneal administration of the PD-1-blocking antibody or isotype-matched control antibody at 1 d after infection. All mice that received the PD-1-blocking antibody succumbed to infection within a week (Fig. 6b) , which resulted in a mortality similar to that of GR Ncr1-iCre mice (Fig. 6a) . Notably, this greater susceptibility to infection was not due to a difference in viral replication rate in GR Ncr1-iCre mice relative to that in WT Ncr1-iCre mice (Fig. 6c ), or in wildtype mice that received the PD-1-blocking antibody relative to that in wild-type mice that received the control antibody ( Fig. 6d ), which suggested that the GR-PD-1 regulatory pathway did not impair viral clearance. Wild-type mice that received the PD-1-blocking antibody had more-substantial immunopathological features in the spleen, with larger areas of coalescing necrotic and granulomatous splenitis in the marginal zone than that of wild-type mice that received the control antibody (Fig. 6e) . In contrast, the severity of hepatic lesions was not affected by blockade of PD-1, with both groups of mice displaying moderate to substantial necrotic and pyogranulomatous 
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The GR-PD-1-IFN-γ pathway prevents spleen immunopathology. PD-1-deficient mice infected with the murine hepatitis virus strain 3 are reported to have severe spleen and liver damage and high expression of FGL2, a molecule involved in fibrinogen deposition 28 . By RT-qPCR, we found no difference in the expression of Fgl2 in spleen tissue homogenates after injection of the PD-1-blocking antibody into MCMV-infected wild-type C57BL/6 J mice relative to its expression in such homogenates of their counterparts given injection of the control antibody (data not shown). To further investigate the mechanisms involved in the immunopathology observed in the MCMV-infected GR Ncr1-iCre mice and mice treated with the PD-1-blocking antibody, we used a cytometric-bead array to measure the concentration of inflammatory cytokines in serum, spleen and liver after infection. At 3 d after infection, the amount of the cytokines IL-6, TNF and IL-10 in the serum and tissues of MCMVinfected GR Ncr1-iCre mice and those of wild-type mice treated with the PD-1-blocking antibody was similar to that of the WT Ncr1-iCre mice and wild-type mice treated with the control antibody, respectively ( Supplementary Fig. 8 ). In contrast, we detected greater IFN-γ production in the spleen and serum, but not in the liver, of MCMVinfected GR Ncr1-iCre mice and those of wild-type mice treated with the PD-1-blocking antibody than in that of WT Ncr1-iCre mice and wildtype mice treated with the control antibody, respectively (Fig. 6f,g) .
To determine whether the NK cell-derived IFN-γ in the spleen of GR Ncr1-iCre mice might have a role in spleen hyper-inflammation and immunopathology, we treated WT Ncr1-iCre and GR Ncr1-iCre mice with an IFN-γ -blocking antibody or an isotype-matched control antibody (IgG1) on day 1 after infection, a time at which the HPA axis was activated. Histological analysis revealed substantial-to-severe inflammation in the spleen of IgG1-treated GR Ncr1-iCre mice on day 3 after infection, with large and coalescing pyogranulomas and necrotic foci throughout the splenic parenchyma (Fig. 7a ). We also observed destruction of the white pulp, including, in particular, the periarteriolar lymphoid sheath (PALS), which displayed decreased cellularity and atrophy in the severely affected areas and partial replacement by necrotic and granulomatous inflammation (Fig. 7a ). Morphometric assessment of the PALS indicated that IgG1-treated GR Ncr1-iCre mice had more-severe destruction of the splenic architecture, with decreased surface of PALS areas on spleen sections, relative to that of IgG1-treated WT Ncr1-iCre mice (Fig. 7b ). In contrast, GR Ncr1-iCre mice treated with the IFN-γ -neutralizing antibody showed 'rescue' of their spleen immunopathology to a level similar 
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to that of WT Ncr1-iCre mice given injection of IgG1 or the IFN-γ -neutralizing antibody (Fig. 7a,b) . Thus, the glucocorticoids produced after infection with MCMV controlled the production of IFN-γ by spleen NK cells and IFN-γ -mediated spleen immunopathology.
Discussion
Here we found that endogenous glucocorticoids produced in response to infection with MCMV selectively induced the expression of PD-1 in spleen NK cells and thus controlled their IFN-γ production and prevented the development of immunopathology in the spleen. This regulatory pathway was organ specific and did not affect viral clearance. PD-1 expression was induced in vitro on NK cells by treatment with glucocorticoids in combination with IL-15 and IL-18, and this effect was abolished when IL-12 was also present. Consistent with that, different inflammatory profiles were observed in the spleen versus the liver of MCMV-infected mice in vivo. Although in vitro experiments cannot reproduce the complex combination of events that occur in the tissues in vivo after infection, they defined the conditions under which PD-1 expression can be induced on NK cells. Ie1 copy number (per mg, log) (key) infected with MCMV (LD 50 ) (a) or of wild-type infected with MCMV (LD 50 ) and then given injection of PD-1-blocking antibody or isotype-matched control antibody (key) (b), assessed at various times (horizontal) after infection. Data are pooled from three experiments with n = 13 mice (a) or two experiments with n = 11 mice (Ig) and n = 10 mice (PD-1 Ab) (b). **P < 0.01 (two-tailed log-rank Mantel-Cox test). c,d, qPCR analysis of Ie1 (as in Fig. 2e ), assessing viral titers in the spleen and liver (horizontal axis) of mice as in a (c) or b (d) (key) at 3 d after infection. Each symbol represents an individual mouse. Data are pooled from two experiments with n = 6 WT Ncr1-iCre mice and n = 9 GR Ncr1-iCre mice (c) or n = 9 mice (Ig) and n = 10 mice (PD-1 Ab) (d) (mean ± s.e.m). e, Histology (H&E staining) of the spleen and liver (left margin) of mice as in b (right margin), assessed 3 d after infection (right, enlargement of areas outlined at left); similar results were obtained with two different anti-PD-1 clones (J43 and RMP1-14). Scale bars, 100 μ m. Data are from n = 4 mice (Ig) and n = 5 mice (PD-1 Ab). f,g, Cytometric-bead array of IFN-γ in the serum, spleen and liver (above plots) of mice as in a (f) or b (g) (key) at 3 d after infection. Each symbol represents an individual mouse. Data are pooled from two experiments (serum) or three experiments (spleen and liver) with n = 7 WT Ncr1-iCre mice (serum), n = 8 GR Ncr1-iCre mice (serum), n = 8 WT Ncr1-iCre mice (spleen and liver) and n = 14 GR Ncr1-iCre mice (spleen and liver) mice (f; mean ± s.e.m.) or are pooled from two experiments with n = 7 mice (Ig, serum), n = 8 mice (PD-1 Ab, serum) and n = 9 mice (spleen and liver) (g; mean ± s.e.m.). *P < 0.05 and **P < 0.01 (two-tailed Mann-Whitney test (serum) or two-tailed Student's t-test (spleen)).
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The correlation between the effect of the cytokines in vitro and their organ-specific expression in vivo suggests that distinct combinations of inflammatory or homeostatic cytokines could act together with corticosterone to induce PD-1 expression on NK cells in the spleen.
Characterization of the precise inflammatory context involved in the corticosterone-induced regulation of PD-1 expression in vivo will require further investigation. For example, PD-1 was expressed on spleen NK cells in vivo despite the induction of Il12 mRNA in this organ. Although we did not measure IL-12 at the protein level, it is possible that different concentrations of recombinant IL-12 in vitro and in the NK cell microenvironment in vivo mediate different effects. We detected the expression of Il18 transcripts in the spleen and liver in vivo but did not detect a significant increase in the transcription of this cytokine-encoding gene in either organ at 44 h after infection. However, as IL-18 is synthesized as an inactive precursor that requires proteolytic cleavage to produce the biologically active cytokine 29 , it is possible that expression of the mature IL-18 protein is regulated at the tissue level. In line with that, expression of mature IL-18 has been reported to be higher in the spleen than in the liver after infection with MCMV 30 , which would provide a possible explanation for the organ-specific induction of PD-1 expression on spleen NK cells.
In the hematopoietic lineage, the regulation of PD-1 expression by glucocorticoids during the early stage of infection with MCMV seemed to be restricted to NK cells. It would be useful to determine whether endogenous glucocorticoids induce PD-1 expression on various immune cells, including T cells, in other pathological contexts, as PD-1 expression has been reported on several subsets of immune cells in other models of viral infection 28, 31, 32 . PD-1 expression is upregulated on T cells during various conditions of activation 26 . The lack of PD-1 induction on T cells early during infection with MCMV observed here would be expected, as T lymphocytes are activated during the later phase of such infection 17 . Moreover, treatment with various combinations of inflammatory cytokines and corticosterone in vitro did not induce PD-1 expression on T cells. Thus, the GR-induced regulation of PD-1 was specific to NK cells in these conditions.
We found that the GR-dependent induction of PD-1 expression on spleen NK cells was needed to control the production of IFN-γ in these cells, which prevented IFN-γ -dependent immunopathology in the spleen. However, the viral load in the spleen of GR Ncr1-iCre mice was similar to that in their WT Ncr1-iCre (control) littermates, which indicated that the downregulation of IFN-γ production by the HPA axis did not compromise the control of viral replication. Similarly, blockade of PD-1 in wild-type mice resulted in a phenocopy of the spleen hyper-inflammation seen in GR Ncr1-iCre mice, and it did not modify the viral load. Consistent with those results, published studies have shown that spleen NK cells exert their antiviral effects in a perforin-dependent manner, suggestive of a major role for cytotoxic mechanisms in this organ 33 . Activation of GR had no effect on the cytotoxic activity of NK cells, which would suggest decoupling of the actions of glucocorticoids on the main antiviral functions of NK cells. In the liver, IFN-γ production by NK cells is a major mechanism for the control of MCMV replication 15, 33, 34 . Despite high concentrations of corticosterone in the serum, PD-1 expression was not upregulated in liver NK cells, and the IFN-γ production of these cells was unaffected. Therefore, the dampening of NK cell function by the HPA axis did not affect the effectiveness of the anti-viral response in either the spleen or the liver.
The glucocorticoid-dependent induction of PD-1 expression on NK cells during infection with MCMV is a previously unrecognized mechanism by which the HPA axis suppresses immunopathology and promotes disease resistance without compromising protective immunity. It will be important to evaluate the role of this pathway in other infectious conditions and in people with inflammatory diseases. Along that line, a population of PD-1 + NK cells has been identified in healthy donors seropositive for human CMV 35 , in people seropositive for human immunodeficiency virus type 1 36 and in patients with Kaposi sarcoma 37 , but the mechanisms by which PD-1 expression is regulated on these cells remain to be addressed. It will be also useful to analyze whether PD-1 expression on immune cells is associated with the immunological dysfunctions observed in people in other conditions in which the HPA axis is activated, such as psychological distress and tissue damage 38 .
Novel immunotherapies that act through the blockade of immunological checkpoints such as PD-1 have yielded outstanding results for advanced cancer 39, 40 . In patients with cancer, inflammatory reactions can be managed with immunosuppressive agents, such as corticosteroids 39 . It will be important to determine in which conditions and on which cells PD-1 expression can be induced by such treatments. Such an analysis could make it possible to identify additional pathological situations in which treatment with antibodies to PD-1 Fig. 7 | IFN-γ neutralization prevents spleen immunopathology in gR Ncr1-iCre mice. a, Histology (H&E staining) of the spleen of WT Ncr1-iCre and GR Ncr1-iCre mice (above plots) infected with MCMV (LD 50 ), then, 1 d later, treated with IFN-γ -neutralizing antibody (IFN-γ Ab) or isotype-matched control antibody (IgG1) (left margin), assessed 3 d after infection. Scale bars, 500 μ m. b, Histopathological quantification of spleen inflammation in mice as in a, assessed by measurement of the area covered by PALS and presented as the proportion of the total area of the spleen section. Each symbol represents an individual mouse; small horizontal lines indicate the mean ( ± s.e.m.). *P < 0.05 (one-way ANOVA). Data are pooled from two experiments with n = 10 WT Ncr1-iCre mice (IgG1), n = 9 GR Ncr1-iCre mice (IgG1), n = 11 WT Ncr1-iCre mice (IFN-γ Ab) and n = 5 GR Ncr1-iCre mice (IFN-γ Ab).
Articles
NATuRe IMMuNoloGy could be effective. Deeper understanding of the physiological and pathological conditions in which this glucocorticoid-PD-1 pathway exerts some beneficial or detrimental effects could provide a rational basis for the development of new therapeutic strategies.
methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0185-0. 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
GraphPad Prism7 was used for the statistical analysis. FlowJo10 was used for the analysis of the FACS data. CaseViewer from 3dhistech was used for the morphometric assessment of histological slides. BioMark HD (Fluidigm) was used for gene expression analysis. HiSat2, bowtie2, MarkDuplicates, featureCounts v1.5.2 and DESeq v1.16.1 were used for bioinformatics analysis.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
